STOCK TITAN

Zai Lab insider Ying Du sold 234,048 ADS for $7.29M; another 50,000 ADS planned

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Zai Lab Limited (ZLAB) filed a Rule 144 notice disclosing a proposed sale of 50,000 American Depositary Shares through Fidelity Brokerage Services with an aggregate market value of $1,731,814.58. The filing lists the securities as acquired by option granted 10/22/2015 and shows an intended sale date of 08/11/2025. The issuer's outstanding shares are listed as 421,725,450, providing context for the size of the transaction.

The filing also lists prior sales by Ying Du during May–August 2025 totaling 234,048 ADS for aggregate gross proceeds of $7,290,892.36. The filer affirms no undisclosed material adverse information and provides broker details for the planned sale.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Documented insider sales continue but represent a small fraction of outstanding shares.

The filing shows a proposed sale of 50,000 ADS valued at $1.73M and a series of prior sales by Ying Du totaling 234,048 ADS for $7.29M in gross proceeds over recent months. Compared with the stated 421,725,450 shares outstanding, these disposals represent a very small percentage of issued securities, suggesting limited immediate dilution or supply shock. This is factual disclosure under Rule 144 and provides clear transaction dates, broker information, and proceeds, which help investors track insider liquidity events.

TL;DR: Repeated insider sales are notable for governance monitoring despite being numerically small versus outstanding shares.

The filing documents multiple sales by the same person

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

2.07B
106.96M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI